New! Make Your CRM Smarter with Best-In-Class Intent Data

Learn More!
Orig3n

Orig3n

Orig3n exists at the intersection of biological science and emerging technology, on a mission to revolutionize the future of medicine. As part of its mission to democratize access to genetic information, Orig3n provides consumers direct, affordable access to information about their lifestyle-related genes, thereby empowering people to make educated, proactive and personalized lifestyle choices that may impact their well-being. Orig3n also invests in breakthrough cell therapy programs by utilizing cutting-edge cellular science to develop personalized therapies for repairing tissue damage and treating disease. Since its inception in 2014, Orig3n has built the largest suite of direct-to-consumer genetic tests on the market, and the world's most comprehensive cell bank for commercial regenerative medicine applications.

Last updated on

About Orig3n

Founded

2014

Estimated Revenue

$10M-$50M

Employees

11-50

Funding / Mkt. Cap

$50M

Category

Industry

Biotechnology

Location

City

Boston

State

Massachusetts

Country

United States

Tech Stack (48)

search